Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Large Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01208064
What this trial is testing

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 102
Not applicableActive Not RecruitingNCT01345851
What this trial is testing

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+6 more
Jonsson Comprehensive Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT00033722
What this trial is testing

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Tularik
Testing effectiveness (Phase 2)Study completedNCT00087412
What this trial is testing

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT00293280
What this trial is testing

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Testing effectiveness (Phase 2)Study completedNCT00278460
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 49
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00728845
What this trial is testing

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Medicine and Dentistry of New Jersey 8
Testing effectiveness (Phase 2)Study completedNCT03575793
What this trial is testing

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung CancerSCLC
Salma Sabbour 39
Early research (Phase 1)Study completedNCT00986297
What this trial is testing

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00003587
What this trial is testing

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 204
Testing effectiveness (Phase 2)Study completedNCT01294306
What this trial is testing

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00950365
What this trial is testing

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Bronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung Adenocarcinoma+3 more
Albert Einstein College of Medicine 79
Early research (Phase 1)UnknownNCT06384482
What this trial is testing

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

Who this might be right for
Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma
Shanghai Simnova Biotechnology Co.,Ltd. 35
Large-scale testing (Phase 3)Study completedNCT00021060
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 842
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Testing effectiveness (Phase 2)Study completedNCT00227708
What this trial is testing

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
UNICANCER 58
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT00073398
What this trial is testing

Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell CarcinomaAdenocarcinoma of LungSquamous Cell Carcinoma+2 more
NewLink Genetics Corporation 54
Next Page